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to the medical center for pharmacist evaluation. CVT policies and procedures jointly developed by pharmacy, telehealth, and CBOC nursing staff require focused training for clinic personnel and informed patient consent to receive CVT services. During the first few months of CVT clinic operations, the mean percentage of time patients' INR values were within the therapeutic range remained stable (about 81%, compared with about 77% under the previous faceto-face clinic model), and a high level of patient satisfaction was maintained. Implementation of CVT anticoagulation monitoring services enabled pharmacist resource reallocation to other duties. Conclusion. Through the use of CVT technology, high-quality anticoagulation services and patient satisfaction were maintained and the allocation of clinical pharmacy specialist resources was optimized. Am J Health-Syst Pharm. 2015; 72:70-3 I n 2006, of the 5.6 million veterans enrolled in the Veterans Affairs (VA) healthcare system, approximately 40% resided in rural areas. 1 Veterans living in rural areas are challenged with limited access to specialty healthcare services and a shortage of medical providers practicing in those communities. Clinical video telehealth (CVT) is a method of providing services to veterans enrolled in community-based outpatient clinics (CBOCs), which can be located in geographic areas where access to healthcare services is limited. CBOCs typically have onsite primary care and limited specialty services.
At the VA Maryland Health Care System (VAMHCS), ambulatory care clinical pharmacy specialists predominantly provide outpatient anticoagulation services under an approved scope of practice. This institution previously designated clinical pharmacy specialists as the healthcare professionals most proficient in providing anticoagulation services. Increasing demands for ambulatory care clinical pharmacy specialists at the Baltimore VA Medical Center (VAMC) in the absence of resources to hire additional staff led the pharmacy department to pursue telehealth technology (also known as telemedicine technology) as a method of delivering anticoagulation services to one of its affiliated CBOCs.
Background
The Institute of Medicine defines telemedicine as "the use of electronic information and communication technologies to provide and support health care when distance separates the participants."
2 Although telehealth is not a new concept, it has evolved with the expansion of health information technology. CVT, a form of telehealth, involves the use of realtime videoconferencing technology to provide patient care remotely by replicating face-to-face visits. CVT connects patients at a clinic or at home to providers at a remote location.
VAMHCS comprises three medical centers, two community living and rehabilitation centers, and six CBOCs. One CBOC is located in a rural community in Fort Howard, Maryland, and serves a small number of veterans (approximately 2000) relative to the other affiliated CBOCs, each of which serves over 4000 veterans. In fiscal year 2012, 145 patients were seen at the anticoagulation clinic at the Fort Howard CBOC, compared with 1866 patients in the anticoagulation clinic at the Baltimore VAMC. Prior to the implementation of CVT, the Fort Howard CBOC anticoagulation clinic was staffed three full days per week by one ambulatory care clinical pharmacy specialist providing face-to-face anticoagulation visits. The purpose of the telehealth project described here was to use CVT technology to optimize ambulatory care clinical pharmacy staff at the Baltimore VAMC while continuing to provide quality anticoagulation services at the CBOC.
A patient care CVT system generally consists of two telehealth stations: one at the patient site and one at the provider site. As implemented at CBOCs operated by VAMHCS, the CVT setup at the patient site consists of a global media cart that holds two adjacent 21.5-inch high-definition (HD), widescreen, touchscreen monitors and a variety of devices for physical assessments. One monitor displays the provider site, and the other displays images obtained using the different devices for physical examination; those images are also displayed at the provider site. Each global media cart within the VAMHCS is customized with an array of devices tailored to the needs of the specific CVT clinic at which the cart is deployed. The CVT station at the provider site has a 24-inch HD monitor that displays images transmitted from the patient site. Video cameras at both the patient and the provider sites can be adjusted to ensure that the desired patient and provider views are obtained. Similar CVT equipment and setups are used at VA facilities nationwide pursuant to a VA contract with a CVT equipment vendor.
Analysis and resolution
Development and implementation. Prior to implementation of the pharmacist-managed CVT anticoagulation clinic in June 2012, limited CVT services had been provided by the VAMHCS. A telehealth coordinator was hired at the Baltimore VAMC to expand CVT clinics throughout the healthcare system. The VAMHCS pharmacy department saw an opportunity to optimize anticoagulation clinic work force efficiency and staff utilization while supporting CVT initiatives. This multidisciplinary effort involved the VAMHCS telehealth coordinator and associate chief of clinical pharmacy services, the Fort Howard CBOC's nurse manager, ambulatory care clinical pharmacy specialists, and CBOC nursing staff and telehealth technicians. All staff members participating in the CVT clinic were required to complete training provided through the VA Office of Telehealth Services prior to initiation of the service. The requisite training modules certify that participants are familiar with the CVT equipment, patient privacy issues, procedures for coding and billing of patient visits, and other special considerations (e.g., adjustment of lighting and audio, equipment troubleshooting) to ensure that the technology does not interfere with providing quality healthcare.
The pharmacy department's administrative review of the CBOC's anticoagulation clinic workload indicated that three half-day CVT clinic sessions would be necessary to maintain adequate access to anticoagulation services. Workload and patient volume were evaluated by comparing the number of appointment slots available per day with the actual number of patients seen per day over a 12-month period. Efficiency was predicted to improve with the use of CVT due to an enhanced ability of clinic personnel to streamline the process from the point of triage to the point of the patient interview.
An initial outline of the CVT anticoagulation clinic workflow was established; this document detailed the roles and responsibilities of the ambulatory care clinical pharmacy specialists, nursing staff, and CVT telehealth technician.
Patients were scheduled for 20-minute appointments, with 12 patient appointments slated per half-day clinic session. The nursing staff obtained data on vital signs and performed point-of-care (POC) International Normalized Ratio (INR) testing. The telehealth technician escorted the patient to the CVT examination room, appropriately positioned the patient in front of the global media cart, adjusted the sound or lighting if necessary, troubleshot technological difficulties, assisted in physical assessments when instructed to do so, and scheduled the patient's next clinic appointment. The clinical pharmacy specialist provided direct patient care, guided the telehealth technician in performing physical assessments when necessary, conducted interviews, evaluated the patient's warfarin therapy, and formulated a therapeutic plan.
During the face-to-face anticoagulation visits conducted prior to CVT clinic implementation, warfarin dosing instructions were transcribed by the clinical pharmacy specialist and provided directly to the patient, a process posing very little risk of transcription errors. With the initiation of the CVT clinic, an alternative method of conveying dosing instructions was necessary; the ambulatory care clinical pharmacy specialist was no longer onsite to give the instructions directly to the patient, and there were concerns that errors might occur if the instructions were transcribed by an alternative CVT clinic staff member. This concern was addressed through the use of a network printer; upon the patient receiving verbal warfarin dosing instructions, the offsite clinical pharmacy specialist used the printer to remotely transmit that information to the CBOC room, thereby minimizing the risk of transcription errors. A standard patient instruction sheet created for the Fort Howard CVT clinic included the patient's warfarin dosing schedule, the warfarin tablet strength and color, the POC INR test result, and information on the next follow-up appointment.
A CVT "cheat sheet" including contact information for the patient and provider sites, phone numbers for troubleshooting, an overview of clinic workflow, and coding and billing information was developed. An electronic note template for documenting patient interactions, which included documentation required by the VA Office of Telehealth Services, was developed. Documentation of patient agreement for participation in the CVT clinic was required at initial visits. All patients previously served through traditional face-toface anticoagulation clinic visits were scheduled into the CVT anticoagulation clinic; however, patients had the opportunity to request that visits be conducted face-to-face at the Baltimore VAMC if they chose not to participate.
During the initial phase of CVT clinic operations, adjustments were made to the clinic workflow to optimize efficiency. These adjustments included training and certifying the telehealth technician to use the POC equipment to obtain INR values. This allowed the telehealth technician to obtain data on vital signs and perform INR testing within the CVT examination room, eliminating the need for a triage room and the involvement of the CBOC nursing staff in INR determinations.
Technological challenges encountered in the months after CVT clinic implementation included power outages at the CBOC, interruptions in Internet service that led to the loss of CVT signals, and the loss of audio or video capability. In those situations, a backup plan set in place prior to CVT clinic implementation was followed; a speakerphone in the CBOC clinic room was utilized to conduct visits via telephone. As time progressed, technological interferences were decreased through system improvements implemented by the telehealth staff and the technology vendor.
Experience with the program. The impact of the use of CVT technology on patients' INR values (i.e., the percentage of time in the therapeutic range [TTR] ) and patient satisfaction was evaluated six months after implementation of the CVT anticoagulation clinic. The method of Rosendaal et al. 3 was used to calculate TTR, and a survey previously approved by the VA Office of Telehealth Services was administered to patients to evaluate patient satisfaction levels. Of the 151 patients enrolled in the Fort Howard CVT anticoagulation clinic, 38 patients were selected for the evaluation, as they had been on uninterrupted anticoagulation for at least 12 months. The mean ± S.D. patient age was 77 ± 10.6 years; all were men, and the majority were Caucasian. The predominant indication for warfarin therapy was atrial fibrillation (Table 1) .
The mean ± S.D. percentage values for TTR among veterans receiving anticoagulation services through the CBOC were comparable before and after CVT implementation (76.4% ± 18.8% versus 80.8% ± 16.1%).
The survey response rate was greater than 80%. The mean ± S.D. patient satisfaction score per survey item was 4.77 ± 0.14 (maximum score, 5), with a mean total survey score of 56.98 ± 4.6 (maximum score, 60) ( Table 2 ). These results suggested that the CVT anticoagulation clinic provided an alternative to face-toface visits that did not appear to compromise the quality or availability of the services delivered.
Discussion
The implementation of the pharmacist-managed CVT anticoagulation clinic revealed an opportunity to utilize real-time video technology to provide pharmaceutical care in a clinic remote from the main provider practice site. Use of innovative CVT technology to deliver anticoagulation services improved the utilization of ambulatory care clinical pharmacy specialists within the VAMHCS while maintaining high-quality services and patient satisfaction. The CVT clinic enabled a beneficial shift in pharmacist fulltime equivalent (FTE) deployment. Prior to CVT implementation, 0.60 FTE was dedicated to providing anticoagulation services; after implementation, 0.30 FTE was used to staff the Fort Howard anticoagulation clinic, allowing deployment of 0.30 FTE to meet the growing demand for ambulatory care clinical pharmacy services at the Baltimore VAMC.
The pharmacist-managed CVT anticoagulation clinic has since been expanded to another CBOC, with the potential for future expansion of CVT clinics at additional CBOCs providing anticoagulation services and other medication therapy management services. Additionally, opportunities in specialty interdisciplinary clinics such as CVT diabetes clinics have become available for ambulatory care clinical pharmacy specialists at the medical center. As the population of veterans continues to grow, and the demands on medical providers increase, opportunities for integration of clinical pharmacy specialists as essential members of the healthcare team continue to increase. By utilizing CVT, these opportunities can exist outside the confines of the clinical pharmacy specialist's physical practice site. As staffing challenges are typically greatest in rural locations, expanding CVT services can improve access to healthcare in those areas. This model can be implemented in a variety of healthcare settings to deliver pharmaceutical care services, including therapeutic drug monitoring, chronic disease management, and patient education.
Conclusion
Through the use of CVT technology, high-quality anticoagulation services and patient satisfaction were maintained and the allocation of clinical pharmacy specialist resources was optimized. Item scores ranged from 1 to 5 (1 = strongly disagree, 5 = strongly agree), with a total maximum score of 60.
1. I felt comfortable with the equipment used. 2. I was able to see the clinician clearly. 3. I was able to hear the clinician clearly. 4. There was enough technical assistance for my meeting with the clinician. 5. My relationship with the clinician was the same during this session as it is in person. 6. The location and time of the telehealth clinic are convenient for me. 7. My needs were met during this session. 8. I received good care during this session. 9. The telehealth clinic provided the care I expected. 10. Overall, I am satisfied with this telehealth session. 11. I would recommend this type of session to other veterans. 12. I would rather use telehealth to receive this service than travel long distance to see my provider. 
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